HDFC Life Insurance Falls Over 3% Post Q2 Results Despite Brokerages Remaining Bullish

Shares of HDFC Life Insurance Company declined over 3% in intraday trade, hitting a low of ₹533 on the National Stock Exchange (NSE) as investors digested the insurer's financial performance for the second quarter. The decline came despite steady headline numbers and an upbeat stance from major brokerage houses.

The stock has faced sustained pressure on the bourses, falling nearly 29% calendar year-to-date. The drop in the counter stood in contrast to the broader market trend, where the benchmark NSE Nifty 50 traded higher near the 23,140 level.

Key Q2 Earnings Highlights

HDFC Life reported a 13.6% year-on-year increase in net profit to ₹508 crore for the quarter ended September, up from ₹447.15 crore in the corresponding period of the previous fiscal.

Financial and operational metrics for the quarter and half-year showed: * Net Premium Income: Rose 15.7% year-on-year to ₹21,727.37 crore compared with ₹18,777.31 crore in the year-ago period. * Value of New Business (VNB): Increased 7.6% year-on-year to ₹1,009 crore in Q2. For the first half (H1), VNB rose 12.1% to ₹2,037 crore. * VNB Margin: Expanded slightly to 24.7% in H1 from 24.5% a year earlier, aided by product mix management. * Annualised Premium Equivalent (APE): Total APE climbed 12.9% year-on-year to ₹4,730 crore in Q2, while H1 total APE reached ₹8,245 crore, up 11%. * Individual WRP Growth: Individual weighted received premium grew 11% in Q2, outpacing the private life insurance industry's 10% average.

Vibha Padalkar, Managing Director and CEO of HDFC Life, noted that individual policy count expanded by 9% in the first half, helping the insurer lift its market share to 16.2% from 16.1% in the first quarter.

Brokerage Views and Outlook

Despite the initial negative market reaction, brokerage firms retained positive views on the stock, citing resilient business generation and manageable underwriting profitability.

Analysts at Systematix Institutional Research reiterated a Buy rating, raising the target price to ₹650 from ₹630. The brokerage noted that the insurer's Q2 VNB beat street expectations by 2.2% and rebounded 31.7% quarter-on-quarter off a lower base. Analysts also flagged the company's board approval to raise up to ₹500 crore via subordinated debt, which is expected to bolster the capital adequacy ratio by around 400 basis points ahead of the impending risk-based capital (RBC) framework rollout.

Elara Securities also maintained a Buy recommendation, pointing out the healthy expansion in individual premium collections and solid recovery in margins despite ongoing headwinds regarding insurance distribution economics and regulatory consultation papers issued by the Insurance Regulatory and Development Authority of India (IRDAI).

Tags: HDFC Life Insurance NSE Nifty 50 BSE Sensex IRDAI Insurance Sector